University of Texas-Austin: Breakthrough in Fight on Tick-Borne CCHF Virus is Latest Use of New Strategy Against Diseases
November 19, 2021
November 19, 2021
AUSTIN, Texas, Nov. 19 (TNSJou) -- The University of Texas issued the following news release:
Using the same approach they recently used to create effective vaccine candidates against COVID-19 and respiratory syncytial virus (RSV), scientists are tackling another virus: the tick-borne Crimean-Congo hemorrhagic fever (CCHF). It causes death in up to 40% of cases, and the World Health Organization identified the disease as one of its top priorities for research and development. The re . . .
Using the same approach they recently used to create effective vaccine candidates against COVID-19 and respiratory syncytial virus (RSV), scientists are tackling another virus: the tick-borne Crimean-Congo hemorrhagic fever (CCHF). It causes death in up to 40% of cases, and the World Health Organization identified the disease as one of its top priorities for research and development. The re . . .